Table 4. Clinical characteristics and... | American Society of Hematology

Table 4.

Clinical characteristics and IPI scores of patients who received RT or chemotherapy as primary treatment

	RT*	Chemotherapy*	P†
No. of patients	7	59
Men	5 (71.4%)	46 (77.9%)
Women	2 (28.6%)	13 (22.1%)	NS (.65)
Age older than 60 y	3 (42.8%)	20 (33.8%)	NS (.68)
Advanced stage (III/IV)	0	11 (18.6%)	NS (.47)
B symptoms	1 (14.3%)	22 (37.3%)	NS (.27)
Elevated LDH level	0	39 (66.7%)	NS (.12)
ECOG score 2 or higher	2 (33.3%)	13 (22.0%)	NS (.69)
IPI 2 or higher	3 (33.3%)	29 (45.7%)	NS (.99)

	RT*	Chemotherapy*	P†
No. of patients	7	59
Men	5 (71.4%)	46 (77.9%)
Women	2 (28.6%)	13 (22.1%)	NS (.65)
Age older than 60 y	3 (42.8%)	20 (33.8%)	NS (.68)
Advanced stage (III/IV)	0	11 (18.6%)	NS (.47)
B symptoms	1 (14.3%)	22 (37.3%)	NS (.27)
Elevated LDH level	0	39 (66.7%)	NS (.12)
ECOG score 2 or higher	2 (33.3%)	13 (22.0%)	NS (.69)
IPI 2 or higher	3 (33.3%)	29 (45.7%)	NS (.99)

NS indicates not significant.

The number in parenthesis represents the percentage of patients in either the RT or chemotherapy group.

P represents the comparison of each categorical variable of the RT with the chemotherapy group, using a 2 × 2 table by χ² or Fisher exact test.